Introduction
Systemic diseases represent a heterogeneous group of diffuse auto-immune and/or auto-inflammatory diseases and syndromes, meaning that usually touches many organs [1] .
The first studies have concluded for the rarity of these affections in Africa [2] .
However, the frequency of the systemic auto-immune diseases was likely to be under-estimated in Africa [3] . Indeed, In Africa, south of the Sahara, these affections are not a concern due to priority areas such as infectious and tropical diseases [4] .
In our region, studies of inflammatory arthritis and autoimmune diseases have been reported. Forty-two (42) cases on connective tissue diseases were reported during 5 years at Ouagadougou [5] . In this study, systemic sclerosis predominated, followed up by lupus disease [5] . In Togo and Abidjan, it was about respectively 84 and 44 patients, with RA as predominant affection [2] [6] . A more recent series in Togo helped to identify 626 cases of inflammatory rheumatism and connective tissue diseases in a period of 16 years [7] .
We found it necessary to conduct a multicentric study about systemic disease in our country.
The aim of our study was to point out these diseases, the spectrum, their epidemiological aspects and the diagnostic delay in Internal Medicine Department of Dakar (Senegal) universities hospitals.
Method of Study

Type of Study
It was a retrospective and observational study carried out from 1 st January 2005 to 30th November 2014. It was carried out on all patient medical records received at external consultation or admitted for a systemic disease in the 5 Internal Medicine Units of Dakar Hospitals.
Population of Study
1) Inclusion Criterias
Were included all patients medical records diagnosed for affections named below, according to the international criterias as follow: o Absence of identifiable causes and/or mechanisms. The approval of the local ethics committee was required.
2) Exclusion criteria
All incomplete medical records that did not allow data exploitation were excluded.
3) Data collection and analysis
The following data were collected: age, sex, diagnosis delay, the presence of prior monitoring, past medical history and comorbidities, clinical, biological, immunological and histological signs lead to conclude to the diagnostic. The diagnosis delay was defined by the duration between the onset of the first clinical manifestation and the date of diagnosis.
The data were recorded through an Excel file. Then, with R software, the Excel database was imported for variable recoding and analysis. The results were presented in text, 
Results
During the period of study, we gathered 962 medical records, 726 were included.
It was 632 females and 94 males, that to say a ratio of 0.14. The average age in our study was 43.76 years with extremes from 16 up to 86 years.
Seventy three (73) patients (10.03%) had a family history of inflammatory rheumatism.
Around one third of our patients (32.23%) had a prior monitoring. It was exclusively about a medical monitoring in 83% of our patients. Two-third of these patients had received only a symptomatic treatment (steroidal and/or non-steroidal anti-inflammatory), without any core therapy in their prior medical monitoring.
5% of the patients saw only traditional healers and 12% of the patients combined traditional treatment with medical treatment.
The mean diagnostic delay duration was 41.52 months (3.46 years). Table 1 points out the distribution of systemic diseases during our study and Table 2 shows the diagnostic time-limit of each systemic condition. Connective tissue diseases were undifferentiated on 20 patients. Table 3 A diagnostic of systemic vasculitis was retained on 19 patients dominated by vasculitis secondary to systemic diseases (see Figure 2 about a case of rheumatoid vasculitis) and Behçet's disease.
The other systemic conditions was represented by systemic sarcoidosis (8 cases), Adult-onset Still's disease (3 cases), Systemic amyloidosis (2 cases) secondary to RA and sarcoidosis and 2 cases of systemic manifestations secondary to immune deficiency.
The comorbidities in our patients are summarized on the (4.6%). Tuberculosis and systemic diseases were associated on 10 patients (1.38%). Table 4 sums up the antecedents and comorbidities in our series.
Discussion
We reported series of 726 patients in a 10 years study period. This multicentric study allowed a complete recruitment, including all Internal Medicine Departments of Dakar hospitals. However, Internal Medicine units do not have the monopoly of systemic diseases recruitment. These affections may be seen, according to their clinical phenotypes in other medical departments. This was a limitation of our study.
Other series of systemic auto-immune diseases were reported in Sub-Saharan Africa. Forty two (42) patients were chosen during 5 years at Ouagadougou [5] .
In this study, systemic sclerosis predominated, followed up by lupus disease [5] .
Down Togo and Abidjan, it was about respectively 84 and 44 patients, with RA as predominant affection [2] [6] . A more recent series in Togo helped to identify 626 cases of inflammatory rheumatism and connective tissue diseases in a period of 16years [7] .
The average age in our study was 43.76 years and around two-third of our pa- [32] .
Belated diagnostic during systemic diseases was confirmed in our study by 41.52 months (3.46 years) average diagnostic time-limit. RA is the condition for which the existence of an interest of an early and "open window" therapy was more documented. The average age of diagnosis of RA was 45.6 months (3.8 years) in our study, 54 months in Ngongo's study, 78 months according to Niasse and 114 months (9.5 years) in Bileckot's study [23] [33] [34] .
Belated diagnostic during systemic diseases would be linked to the lack of knowledge of these affections, the existence of particular way as the use of traditional medicine, the lack of specialists and the high cost of means of explorations in our areas. The association Tuberculosis-Systemic disease was recorded in 10 patients in our study (1.38%). It was rarely reported in African literature despite the endemicity of tuberculosis in our areas and the predisposing terrain of systemic diseases [35] . However it should be taken as a matter of concern especially with the advent of biological therapies.
Conclusion
Systemic diseases in our study are characterized by their diversity, the predominance of rheumatoid arthritis and their belated diagnosis. Improving diagnostic procedures will help to cover systemic diseases in Africa.
